Exploring how certain metals help create new drugs more efficiently
Understanding Geometric and Electronic Structure Contributions to Ground and Excited State Cu- and Ni-Catalyzed Cross-Coupling Reactions
['FUNDING_OTHER'] · CALIFORNIA INSTITUTE OF TECHNOLOGY · NIH-11032838
This study is looking at how certain metals, like copper and nickel, can help create new medicines more efficiently and sustainably by using light to drive chemical reactions, which could lead to better treatments for various health conditions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CALIFORNIA INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (PASADENA, UNITED STATES) |
| Trial ID | NIH-11032838 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the methods used to synthesize drugs by investigating how first-row transition metals, like copper and nickel, can catalyze important chemical reactions. By understanding the geometric and electronic structures of these metals, the research aims to uncover new pathways for drug synthesis that are more sustainable and efficient. The project combines thermal catalysis with photochemistry to explore how light can drive chemical reactions that typically wouldn't happen. This could lead to significant advancements in the development of new therapeutic agents.
Who could benefit from this research
Good fit: Patients who could benefit from this research are those in need of new and effective drug therapies, particularly for conditions that require innovative treatment options.
Not a fit: Patients who are not seeking new drug therapies or those with conditions that are already well-managed by existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and sustainable methods for drug synthesis, potentially lowering costs and increasing the availability of new therapies.
How similar studies have performed: Other research has shown promise in using first-row transition metals for catalysis, indicating that this approach could lead to meaningful advancements in drug synthesis.
Where this research is happening
PASADENA, UNITED STATES
- CALIFORNIA INSTITUTE OF TECHNOLOGY — PASADENA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HADT, RYAN G — CALIFORNIA INSTITUTE OF TECHNOLOGY
- Study coordinator: HADT, RYAN G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.